During the past decade, Clinique Rhône Durance conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 4 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Rhône Durance" #1 sponsor was "Medtronic" with 3 trials, followed by "MicroPort CRM" with 3 trials sponsored, "Biotronik AG" with 2 trials sponsored, "ID3 Medical" with 2 trials sponsored and "Ipsen" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Rhône Durance" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Clinique Pasteur Toulouse" with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Rhône Durance" are "Coronary Artery Disease" (5 trials), "Peripheral Arterial Disease" (4 trials), "Prostate Cancer" (4 trials), "Heart Failure" (3 trials) and "Advanced Prostate Cancer" (1 trials). Many other conditions were trialed in "Clinique Rhône Durance" in a lesser frequency.

Most popular intervention types in "Clinique Rhône Durance" are "Device" (19 trials), "Other" (4 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "ABSORB scaffold" (1 trials), "Altis Single Incision Sling" (1 trials), "Conventional antidiabetic treatment" (1 trials), "Diamondback 360TM orbital atherectomy system" (1 trials) and "Drug Eluting Stent (DES)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Rhône Durance" are 26 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Rhône Durance". 1 are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Clinique Rhône Durance, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Rhône Durance, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".